The role of poly adenosine diphosphate ribose polymerase inhibitors in breast and ovarian cancer: Current status and future directions
Fiona Chionh, Gillian Mitchell, Geoffrey J Lindeman, Michael Friedlander, Clare L Scott
Asia-Pacific Journal of Clinical Oncology | WILEY | Published : 2011
Awarded by National Health and Medical Research Council
Awarded by Victorian Cancer Agency
The authors acknowledge the following funding and support: FC National Health and Medical Research Council Post-Graduate Medical Scholarship 1017737; GJL National Health and Medical Research Council Research Fellowship 637307; CS Clinical Fellowship CRF10_20, Victorian Cancer Agency. The authors thank the research staff, patients and families involved in clinical trials of PARP inhibitors.